StocksX › XYF

X Financial (XYF) — Earnings Call X-Ray

Our AI read all 27 of XYF's earnings calls (2018–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2025 · sign up to see
Previous Call Grade
A
Q4 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
27
2018–2025
Avg Candor
6.1/9
evasion 3/9
Guidance RaisedPromotional ToneSkeptic ReassuredClean CallVolume Step-UpMargins ExpandingDemand AcceleratingCFO Dominates

Call-by-call analysis

🔒 Q1 2025 earnings call 2025-05-20 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2025 call grade is ready
The full 37-point AI read of XYF's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

A Q4 2024 earnings call 2025-03-20

Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.

Guidance: raisedDemand: acceleratingMargins: expandingPricing: stable 2 analysts · 4 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead⚑ Reads rehearsed
Candor 6/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 7/9
Stress 1/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q3 2024 earnings call 2024-11-27

Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics.

Guidance: raisedDemand: acceleratingMargins: expanding 2 analysts · 3 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead⚑ Reads rehearsed
Candor 5/9
Specificity 7/9
Evasion 4/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 3/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q2 2024 earnings call 2024-08-22

Management raised guidance against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Guidance: raisedDemand: acceleratingMargins: expandingPricing: stable 1 analysts · 4 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 3/9
Promotion 3/9
Stress 1/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2024-05-31

Management held guidance steady against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: expanding 1 analysts · 2 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedCFO dominates
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 6/9
Uncertainty 4/9
Promotion 4/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q4 2023 earnings call 2024-03-27

Management gave no formal guidance against slowing demand and contracting margins. The delivery was rich in specifics.

Demand: slowingMargins: contracting 3 analysts · 4 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritableDirection beats results
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 5/9
Uncertainty 5/9
Promotion 2/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q3 2023 earnings call 2023-11-23

Management held guidance steady against accelerating demand and contracting margins. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: contractingPricing: under pressure
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
Candor 6/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 3/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q2 2023 earnings call 2023-08-29

Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning.

Guidance: raisedDemand: acceleratingMargins: expandingPricing: stable 1 analysts · 4 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 8/9
Uncertainty 2/9
Promotion 6/9
Stress 1/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q1 2023 2023-05-25 D maintainedstableexpanding 7/9 5/9
Q4 2022 2023-03-31 D raisedacceleratingexpanding 6/9 5/9
Q3 2022 2022-11-17 D maintainedacceleratingcontracting 6/9 4/9
Q2 2022 2022-08-09 B raisedacceleratingexpanding 6/9 2/9
Q1 2022 2022-05-24 F maintainedstablecontracting 6/9 3/9
Q4 2021 2022-03-31 F maintainedstableexpanding 6/9 4/9
Q3 2021 2021-11-23 F loweredslowingexpanding 6/9 3/9
Q2 2021 2021-08-10 C+ raisedacceleratingexpanding 6/9 4/9
Q1 2021 2021-06-16 B+ raisedacceleratingexpanding 5/9 0/9
Q4 2020 2021-04-26 C raisedacceleratingcontracting 7/9 2/9
Q3 2020 2020-12-02 F withdrawnacceleratingcontracting 6/9 4/9
Q2 2020 2020-08-21 D raisedacceleratingcontracting 6/9 2/9
Q1 2020 2020-06-30 F loweredmixedcontracting 7/9 2/9
Q4 2019 2020-04-29 D loweredmixedcontracting 7/9 1/9
Q3 2019 2019-11-21 F loweredstablecontracting 4/9 5/9
Q2 2019 2019-08-19 D maintainedstablestable 6/9 4/9
Q1 2019 2019-05-21 C maintainedstableexpanding 6/9 3/9
Q4 2018 2019-03-19 C maintainedacceleratingstable 7/9 2/9
Q3 2018 2018-11-20 F nonemixedstable 7/9 4/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAXN · Axon Enterprise'sACIC · American Coastal InsuranACSAF · ACS, Actividades de ConsACU · Acme United CorporationADC · Agree Realty CorporationADPT · Adaptive Biotechnologies

XXII   All “X” companies    XYL

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.